BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17638873)

  • 1. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.
    Singer S; Socci ND; Ambrosini G; Sambol E; Decarolis P; Wu Y; O'Connor R; Maki R; Viale A; Sander C; Schwartz GK; Antonescu CR
    Cancer Res; 2007 Jul; 67(14):6626-36. PubMed ID: 17638873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposarcoma: new entities and evolving concepts.
    Dei Tos AP
    Ann Diagn Pathol; 2000 Aug; 4(4):252-66. PubMed ID: 10982304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma.
    Fritz B; Schubert F; Wrobel G; Schwaenen C; Wessendorf S; Nessling M; Korz C; Rieker RJ; Montgomery K; Kucherlapati R; Mechtersheimer G; Eils R; Joos S; Lichter P
    Cancer Res; 2002 Jun; 62(11):2993-8. PubMed ID: 12036902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
    Boland JM; Colby TV; Folpe AL
    Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma.
    Hisaoka M; Matsuyama A; Nakamoto M
    Am J Pathol; 2012 May; 180(5):2076-83. PubMed ID: 22429966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dedifferentiated liposarcoma with lipoma-like well-differentiated liposarcoma: clinicopathological study of 30 cases, with particular attention to the comingling pattern of well- and dedifferentiated components: a proposal for regrouping of the present subclassification of well-differentiated liposarcoma and dedifferentiated liposarcoma.
    Iwasa Y; Nakashima Y
    Int J Surg Pathol; 2013 Feb; 21(1):15-21. PubMed ID: 22674916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on liposarcoma: a review for cytopathologists.
    Dodd LG
    Diagn Cytopathol; 2012 Dec; 40(12):1122-31. PubMed ID: 21932353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature.
    Boltze C; Schneider-Stock R; Jäger V; Roessner A
    Pathol Res Pract; 2001; 197(8):563-8. PubMed ID: 11518050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-1 regulates adipogenesis: new insights in dedifferentiated liposarcoma tumorigenesis.
    Zaragosi LE; Dadone B; Michiels JF; Marty M; Pedeutour F; Dani C; Bianchini L
    Carcinogenesis; 2015 Jan; 36(1):32-40. PubMed ID: 25344834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis.
    Wu YV; Okada T; DeCarolis P; Socci N; O'Connor R; Geha RC; Joy Somberg C; Antonescu C; Singer S
    Genes Chromosomes Cancer; 2012 Apr; 51(4):313-27. PubMed ID: 22170698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft tissue liposarcoma: histological subtypes, MRI and CT findings.
    Barile A; Zugaro L; Catalucci A; Caulo M; Di Cesare E; Splendiani A; Gallucci M; Masciocchi C
    Radiol Med; 2002 Sep; 104(3):140-9. PubMed ID: 12471362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
    Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
    Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of p53 and MDM2 expressions in liposarcoma with World health organization classification.
    Arici A; Ozgur T; Ugras N; Yalcinkaya U
    Indian J Cancer; 2013; 50(3):164-9. PubMed ID: 24061453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.
    Yu PY; Balkhi MY; Ladner KJ; Alder H; Yu L; Mo X; Kraybill WG; Guttridge DC; Iwenofu OH
    Lab Invest; 2016 Apr; 96(4):481-91. PubMed ID: 26878133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma.
    Fricke A; Cimniak AFV; Ullrich PV; Becherer C; Bickert C; Pfeifer D; Heinz J; Stark GB; Bannasch H; Braig D; Eisenhardt SU
    Cancer Biomark; 2018; 22(2):199-207. PubMed ID: 29689704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
    Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
    Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
    Creytens D; Van Gorp J; Speel EJ; Ferdinande L
    Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
    Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
    J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma.
    Dei Tos AP; Doglioni C; Piccinin S; Maestro R; Mentzel T; Barbareschi M; Boiocchi M; Fletcher CD
    J Pathol; 1997 Jan; 181(1):8-13. PubMed ID: 9071997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.